Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 7Completed 4Terminated 2Recruiting 2Enrolling by invitation 2Withdrawn 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Sarcoma 1

Conditions

Gastrointestinal Stromal Tumors 1Clinical Stage I Gastric Cancer AJCC v8 1

Interventions

Cisplatin 4130-nm albumin-bound paclitaxel 3camrelizumab 2Oxaliplatin 2Nivolumab 2Magnetic Resonance Spectroscopy 2Laparoscopy 2Bevacizumab 2trilaciclib 1trastuzumab deruxtecan 1toripalimab 1selinexor 1sacituzumab govitecan 1ribociclib 1olaparib 1nimotuzumab 1lenvatinib 1fluorodopa F 18 1durvalumab 1decitabine and cedazuridine drug combination 1dalpiciclib 1cemiplimab 1carfilzomib 1apatinib 1anlotinib 1abemaciclib 1Valacyclovir 1Temozolomide 1Taxes 1Surgical Procedures, Operative 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Enrolling by invitation × Laparoscopy × Clear all
NCT07550582 2026-04-30

SAVE-GEJ

Peking University People's Hospital

Phase 2 Enrolling by invitation
40 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT07139951 2025-12-31

HORIZON

Mayo Clinic

Phase 2 Enrolling by invitation
16 enrolled
Gastrointestinal

Clinical Stage I Gastric Cancer AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon âš¡